0.2300USD-4.17%Mkt Cap: 99.02M USDP/E: —Last update: 2026-06-01
Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap99.02M USD
Enterprise Value81.93M USD
Revenue (TTM)34.56M USD
Gross Profit-78.11M USD
Net Income (TTM)-122.93M USD
Revenue/Share0.1070 USD
Last Price0.2300 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees142
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS8006771062
Valuation
P/E (Trailing)—
P/E (Forward)43.98
PEG—
EV/EBITDA-0.77
EV/Revenue2.37
P/S2.64
P/B-4.78
EPS (TTM)-0.38
EPS (Forward)0.01
52W Range
0.100019% of range0.7700
52W High0.7700 USD
52W Low0.1000 USD
Profitability
Gross Margin-226.04%
Oper. Margin-2215.39%
EBITDA Margin0.00%
Profit Margin-310.81%
ROE861.59%
ROA-205.76%
Growth
Revenue Growth-77.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-97.21M USD
CapEx (TTM)102.00K USD
FCF Margin-135.92%
FCF Yield-47.44%
Net Debt-8.25M USD
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity-1.88
Current Ratio0.70
Quick Ratio0.64
Book Value/Sh-0.0460 USD
Cash/Share0.0670 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)2.500 USD
Target Range1.000 USD – 5.000 USD
# Analysts4
Ownership
Shares Out.414.29M
Float410.04M
Insiders1.76%
Institutions25.85%
Short Interest
Short Ratio5.5d
Short % Float10.42%
Short % Out.10.35%
Shares Short42.88M
Short (prev mo.)33.48M
Technical
SMA 500.2242 (+2.6%)
SMA 2000.4275 (-46.2%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)13.55M
Avg Vol (10d)3.48M
Technical Indicators
RSI (14)62.4
MACD-0.0054
MACD Signal-0.0222
MACD Hist.+0.0168
BB Upper0.2205 USD
BB Middle0.1500 USD
BB Lower0.0794 USD
BB Width94.11%
ATR (14)0.0347 USD
Vol Ratio (20d)0.11x